Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands.

Saved in:
Bibliographic Details
Title: Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands.
Authors: van Laarhoven H; Department of Medical Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment & Quality of Life, Amsterdam, the Netherlands., Verhoeven R; Department of Medical Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment & Quality of Life, Amsterdam, the Netherlands.; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., van Berge Henegouwen M; Cancer Center Amsterdam, Cancer Treatment & Quality of Life, Amsterdam, the Netherlands.; Department of Surgery, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, the Netherlands., Mohammad NH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands., Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands., Wijnhoven B; Division of Surgical Oncology and Gastrointestinal Surgery, Department of Surgery, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands., Beerepoot L; Department of Medical Oncology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Nieuwenhuijzen G; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Derks S; Cancer Center Amsterdam, Cancer Treatment & Quality of Life, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam UMC Location Free University, Amsterdam, the Netherlands., van Rossum PSN; Cancer Center Amsterdam, Cancer Treatment & Quality of Life, Amsterdam, the Netherlands.; Department of Radiation Oncology, Amsterdam UMC Location Free University Amsterdam, Amsterdam, the Netherlands.
Source: EClinicalMedicine [EClinicalMedicine] 2025 Jan 22; Vol. 80, pp. 103067. Date of Electronic Publication: 2025 Jan 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2024.103067